Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
these questions, we use a novel multi-omics approach that integrates high-throughput imaging and machine learning methods with CRISPR/Cas9 screens and saturation mutagenesis to answer central questions about the
-
-leading research in several fields. Notably, the groundbreaking discovery of the CRISPR-Cas9 gene-editing tool, which was awarded the Nobel Prize in Chemistry, was made here. At Umeå University, everything
-
microscopy, CRISPR, omics approaches (Chip-seq, proteomics), or bioinformatics. How to apply: Cover letter: your motivation to apply for this position and description of your research interests. CV: Highlight
-
CRISPR screening, single-cell transcriptomics, proteomics, metabolomics, and network reconstruction. Former trainees of the Chi lab have been principal investigators in multiple academic institutions
-
knockouts or knockdowns in patient-derived iPSCs (via CRISPR-Cas9 or siRNA), after which the iPSCs would be differentiated into neutrophils. The phenotypic effect of these interventions would then be verified
-
., spatial transcriptomics, single-cell transcriptomics, metagenomics), bioinformatics (including machine learning and artificial intelligence), synthetic biology, organoid technology, CRISPR, molecular
-
therapeutic strategies, with a focus on precision and patient-oriented approaches. https://nastalylab.gumed.edu.pl THE RESPONSIBILITIES OF THE PERSON EMPLOYED IN THIS POSITION WILL INCLUDE: Conducting
-
opportunity to pursue an independent programme of research in this critical area and to join Oxford University’s Tuberculosis Grand Challenge (https://www.ineosoxford.ox.ac.uk/ioi-grand-challenge-tuberculosis
-
in HIV-1 transcription and telomerase. The research scientist must have experience and skill with cell-line engineering by CRISPR-Cas, RNA structure probing experiments such as DMS and SHAPE-Map
-
CeMM - Research Center for Molecular Medicine of the Austrian Academy of Sciences | Austria | about 2 months ago
Nature), for high-content CRISPR screening (Bock 2022 Nature Reviews), and CAR T cell engineering (Datlinger 2025 Nature); Condensates, Chromatin and Translational Control in Pediatric Cancer (Grebien Lab